Subscribe to Inc. magazine
HEALTH CARE

We've Seen the Future of Translational Medicine and It's Disruptive

A look at work that will get research out of the lab and to patients more cheaply and efficiently.

A team of 110 researchers and clinicians, in therapeutics, diagnostics, devices, and digital health in 25 teams at UCSF, has just shown us the future of translational medicine.  It’s lean, it’s fast, it works, and it’s unlike anything else ever done.

It’s going to get research from the lab to the bedside cheaper and faster.

Welcome to the Lean LaunchPad for Life Sciences and Healthcare (part of the National Science Foundation I-Corps).

This post is part of our series on the Lean Startup in Life Science and Health Care.

Our class talked to 2,355 customers, tested 947 hypotheses and invalidated 423 of them.  They had 1,145 engagements with instructors and mentors. (We kept track of all this data by instrumenting the teams with LaunchPad Central software.)

In a packed auditorium in Genentech Hall at UCSF, the teams summarized what they learned after 10 weeks of getting out of the building. This was our version of Demo Day - we call it "Lessons Learned" Day. Each team made two presentations:

  • Two-minute YouTube video: General story of what they learned from the class
  • Eight-minute Lessons Learned presentation: Very specific story about what they learned in 10 weeks about their business model

In the next few posts I’m going to share a few of the final "Lessons Learned" presentations and videos and then summarize lessons learned from the teaching team.

Magnamosis
Magnamosis is a medical device company that has a new way to create a magnetic compression anastomosis (a surgical connection between two tubular structures like the bowel) with improved outcomes.

anastomosis

Team Members were: Michael Harrison (the father of fetal surgery), Michael DantyDillon KwiatElisabeth Leeflang, and Matt Clark. Jay Watkins was the team mentor.

Their initial idea was that making an anastomosis that’s better, faster, and cheaper will have surgeons fighting to the death to get a hold of their device.

 magnamosis

They quickly found out that wasn’t the case.  Leak rates turned out to be a bigger issue with surgeons and a much larger market.

Here’s their two-minute video summary:

If you can’t see the video above, click here.

Look at their Lesson Learned slides below and see how a team of doctors learned about product/market fit, channels, and pricing. (Don’t miss the evolution of their business model in the Appendix.)

If you can’t see the presentation above, click here.

The best summary of why scientists, engineers and principal investigators need to get out of the building was summarized by Dr. Harrison below. After working on his product for a decade listen to how 10 weeks of the Lean LaunchPad class radically changed his value proposition and business model.

If you can’t see the video above, click here.

 

 

More:
Last updated: Dec 17, 2013

STEVE BLANK | Columnist | Founder, E.piphany, Convergent & Zilog

Steve Blank is a retired Silicon Valley serial entrepreneur turned educator who developed the Customer Development methodology that changes the way startups are built. His book The Four Steps to the Epiphany launched the Lean Startup movement.

The opinions expressed here by Inc.com columnists are their own, not those of Inc.com.



Register on Inc.com today to get full access to:
All articles  |  Magazine archives | Livestream events | Comments
EMAIL
PASSWORD
EMAIL
FIRST NAME
LAST NAME
EMAIL
PASSWORD

Or sign up using: